PTEN and endometrial cancer: It can be seen that PTEN, as a potential predictor of PARP efficacy, can provide a basis for the precise stratification and treatment of endometrial cancer patients if its expression is predicted early, thus optimizing individualized treatment and avoiding exposure to ineffective drugs.